NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Market Update: Corporate Developments Drive Activity on April 22

Several stocks remained in focus on April 22 as corporate developments, earnings updates, and regulatory triggers drove market activity. Key among these were HCL Technologies and Aurobindo Pharma, whose share prices were affected by recent announcements.

HCL Technologies' share price slipped more than 8 percent after posting smaller-than-expected fourth-quarter revenue and net profit. Despite this, the IT services firm reported a 4% rise in consolidated net profit at Rs 4,488 crore and revenue jumped 12.3% at Rs 33,981 crore for the quarter ended March 31, 2026.

In contrast, Cyient DLM's shares jumped 4.5% despite a 27.7% fall in its Q4 net profit to Rs 22.4 crore against Rs 31 crore, year-over-year (YoY). On the other hand, Tata Elxsi's share price declined more than 2 percent despite better Q4 earnings with profit surging 27.8% to Rs 220.4 crore against Rs 172.4 crore, YoY.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Pharma major Aurobindo Pharma's shares traded marginally lower after the company set April 23 as the opening date for its Rs 800 crore buyback offer, with the closing date for the buyback being April 29.

Meanwhile, PNC Infratech's shares rose nearly 9 percent after the company emerged as the lowest (L1) bidder for two HAM-based national highway projects worth Rs 3,483 crore. BEML's shares also surged 5 percent after the company secured an order from the Ministry of Defence for the supply of trawl assemblies, with a contract value of Rs 590 crore.

CompanyShare Price ChangeQ4 Net Profit (YoY)Q4 Revenue (YoY)
HCL Technologies-8%4%12.3%
Cyient DLM4.5%-27.7%N/A
Tata Elxsi-2%27.8%N/A
Aurobindo Pharma---
PNC Infratech9%N/AN/A
BEML5%N/AN/A

Market participants said news flow remains a key driver in the current environment, with investors closely tracking corporate announcements and sector-specific triggers. With earnings season in progress, company-specific updates are expected to drive further volatility.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Investor Takeaway

Investors should be cautious of HCL Technologies' decline and monitor the company's performance.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.